Does matrix metalloproteinase-3 polymorphism play a role in age-related macular degeneration in patients with myocardial infarction?

Medicina (Lithuania)

Volumn 48, Issue 8, 2012, Pages 404-409

  Liutkevičiene, Rasa ^a   Žaliaduonyte Pekšiene, Diana ^a   Žaliuniene, Dalia ^a   Gustiene, Olivija ^a   Jašinskas, Vytautas ^a   Lesauskaite, Vaiva ^b   Tamošiunas, Abdonas ^b   Žaliunas, Remigijus ^a  

^a LITHUANIAN UNIVERSITY OF HEALTH SCIENCES   (Lithuania)

^b LITHUANIAN UNIVERSITY OF HEALTH SCIENCES   (Lithuania)

Author keywords

Age related macular degeneration; Matrix metalloproteinase 3 gene polymorphism; Myocardial infarction; Neovascularization

Indexed keywords

EID: 84872560027     PISSN: 1010660X     EISSN: None     Source Type: Journal    
DOI: 10.3390/medicina48080060     Document Type: Article

References (36)

1. Klein R, Peto T, Bird A, Vannewkirk MR. The epidemiology of age-related macular degeneration. Am J Ophthalmol 2004;137:486-95.
2. Friedman DS, O'Colmain BJ, Muñoz B, Tomany SC, Mc-Carty C, de Jong PT, et al. Prevalence of age-related macular degeneration in the United States. Arch Ophthalmol 2004;122:564-72.
3. Cimbalas A, Paunksnis A, Cerniauskiene LR, Domarkiene S. Prevalence and risk factors of age-related macular degeneration. Medicina (Kaunas) 2004;39:37-43.
4. Fraser-Bell S, Wu J, Klein R, Azen SP, Varma R. Smoking, alcohol intake, estrogen use, and age-related macular degeneration in Latinos: the Los Angeles Latino Eye Study. Am J Ophthalmol 2006;14:79-87.
5. Seddon JM, George S, Rosner B. Cigarette smoking, fish consumption, omega-3 fatty acid intake, and associations with age-related macular degeneration: the US Twin Study of Age-Related Macular Degeneration. Arch Ophthalmol 2006;124:995-1001.
6. Liutkeviciene R, Lesauskaite V, Ašmoniene V, Žaliuniene D, Jašinskas V. Factors determining age-related macular degeneration: a current view. Medicina (Kaunas) 2010;46:89-94.
7. Clemons TE, Milton RC, Klein R, Seddon JM, Ferris FL 3rd; Age-Related Eye Disease Study Research Group. Risk factors for the incidence of advanced age-related macular degeneration in the Age-Related Eye Disease Study (AREDS). AREDS report no. 19. Ophthalmology 2005;112:533-9.
8. Zaliuniene D, Jasinskas V, Jurkevicius R, Gustiene O, Zaliunas R. Endothelial function, intima-media thickness, and ankle-brachial index in patients with cataract and age-related macular degeneration. Eur J Ophthalmol 2008;18:384-91.
9. Zarbin MA. Current concepts in the pathogenesis of agerelated macular degeneration. Arch Ophthalmol 2004;122: 598-614.
10. Ye S. Polymorphism in matrix metalloproteinase gene promoters: implication in regulation of gene expression and susceptibility of various diseases. Matrix Biol 2000;19:623-9.
11. Tatar O, Adam A, Shinoda K, Eckert T, Scharioth GB, Klein M, et al. Matrix metalloproteinases in human choroidal neovascular membranes excised following verteporfin photodynamic therapy. Br J Ophthalmol 2007;91:1183-9.
12. Lesauskaite V, Šinkunaite G, Benetis R, Grabauskas V, Vaškelyte J, Smalinskiene A, et al. Matrix metalloproteinase-3 gene polymorphism and dilatative pathology of ascending thoracic aorta. Medicina (Kaunas) 2008;44:386-91.
13. Samnegard A, Silveira P, Lundman S, Boquist S, Odeberg J, Hulthe J, et al. Serum matrix metalloproteinase-3 concentration is influenced by MMP-3 1612 5A/6A promoter genotype and associated with myocardial infarction. J Intern Med 2005;258:411-9.
14. Alge-Priglinger CS, Kreutzer T, Obholzer K, Wolf A, Mempel M, Kernt M, et al. Oxidative stress-mediated induction of MMP-1 and MMP-3 in human RPE cells. Invest Ophthalmol Vis Sci 2009;50:5495-503.
15. Steen B, Sejersen S, Berglin L, Seregard S, Kvanta A. Matrix metalloproteinases and metalloproteinase inhibitors in choroidal neovascular membranes. Invest Ophthalmol Vis Sci 1998;39:2194-200.
16. Chylack LT Jr, Wolfe JK, Singer DM, Leske MC, Bullimore MA, Bailey IL, et al. The Lens Opacities Classification System III. The Longitudinal Study of Cataract Study Group. Arch Ophthalmol 1993;111:831-6.
17. Duan Y, Mo J, Klein R, Scott IU, Lin HM, Caulfield J, et al. Age-related macular degeneration is associated with incident myocardial infarction among elderly Americans. Ophthalmology 2007;114:732-7.
18. Friedman E. The role of the atherosclerotic process in the pathogenesis of age-related macular degeneration. Am J Ophthalmol 2000;130:658-63.
19. Sun C, Klein R, Wong TY. Age-related macular degeneration and risk of coronary heart disease and stroke: the Cardiovascular Health Study. Ophthalmology 2009;116:1913-9.
20. Tan JS, Mitchell P, Smith W, Wang JJ. Cardiovascular risk factors and the long-term incidence of age-related macular degeneration: the Blue Mountains Eye Study. Ophthalmology 2007;114:1143-50.
21. Wong TY, Tikellis G, Sun C, Klein R, Couper DJ, Sharrett AR. Age-related macular degeneration and risk of coronary heart disease: the atherosclerosis risk in communities study. Ophthalmology 2007;114:86-91.
22. Tan JS, Wang JJ, Liew G, Rochtchina E, Mitchell P. Agerelated macular degeneration and mortality from cardiovascular disease or stroke. Br J Ophthalmol 2008;92:509-12.
23. Bao-Anh NK, Earl L, Goehring EL Jr, Werther W, Gower EW, Do DV, et al. Hospitalized cardiovascular diseases in neovascular age-related macular degeneration. Arch Ophthalmol 2008;126:1280-6.
24. Curcio CA, Millican CL, Bailey T, Kruth HS. Accumulation of cholesterol with age in human Bruch's membrane. Invest Ophthalmol Vis Sci 2001;42:265-74.
25. Wilson PW, D'Agostino RB, Daniel Levy D, Belanger AM, Silbershatz H, Kannel WB. Prediction of coronary heart disease using risk factor categories. Circulation 1998;97:1837-47.
26. Morrow DA, Bernard JG, Braunwald E. Chronic coronary artery disease. In: Zipes DP, Libby P, Bonow RO, Braunwald E, editors. Braunwald's heart disease: a textbook of cardiovascular medicine. Philadelphia, PA: Elsevier Inc; 2007. p. 1281-342.
27. Redberg RF, Benjamin EJ, Bittner V, Braun LT, Goff DC Jr, Havas S, et al. AHA/ACCF [corrected] 2009 performance measures for primary prevention of cardiovascular disease in adults: a report of the American College of Cardiology Foundation/American Heart Association task force on performance measures (writing committee to develop performance measures for primary prevention of cardiovascular disease): developed in collaboration with the American Academy of Family Physicians; American Association of Cardiovascular and Pulmonary Rehabilitation; and Preventive Cardiovascular Nurses Association: endorsed by the American College of Preventive Medicine, American College of Sports Medicine, and Society for Women's Health Research. Circulation 2009;120:1296-336.
28. Spilsbury K, Garrett KL, Shen WY, Constable IJ, Rakoczy PE. Overexpression of vascular endothelial growth factor (VEGF) in the retinal pigment epithelium leads to the development of choroidal neovascularization. Am J Pathol 2000;157:135-44.
29. Ogata N, Wada M, Otsuji T, Jo N, Tombran-Tink J, Matsumura M. Expression of pigment epithelium-derived factor in normal adult rat eye and experimental choroidal neovascularization. Invest Ophthalmol Vis Sci 2002;43:1168-75.
30. Guo L, Hussain AA, Limb GA, Marshall J. Age-dependent variation in metalloproteinase activity of isolated human Bruch's membrane and choroid. Invest Ophthalmol Vis Sci 1999;40:2676-82.
31. Kohri T, Moriwaki M, Nakajima M, Tabuchi H, Shiraki K. Reduction of experimental laser induced choroidal neovascularization by orally administered BPHA, a selective metalloproteinase inhibitor. Graefes Arch Clin Exp Ophthalmol 2003;241:943-52.
32. Woessner JF Jr. Matrix metalloproteinases and their inhibitors in connective tissue remodeling. FASEB J 1991;5:2145-54.
33. Beyzade S, Zhang S, Wong YK, Day IN, Eriksson P, Ye S. Influences of matrix metalloproteinase-3 gene variation on extent of coronary atherosclerosis and risk of myocardial infarction. J Am Coll Cardiol 2003;41:2130-7.
34. Seifi M, Fallah S, Firoozrai M. Influence of genetic polymorphism in matrix metalloproteinase-3 on extent of coronary atherosclerosis and risk of coronary artery stenosis. Arch Med Res 2009;40:600-4.
35. Djuric T, Zivkovic M, Radak D, Jekic D, Radak S, Stojkovic L, et al. Association of MMP-3 5A/6A gene polymorphism with susceptibility to carotid atherosclerosis. Clin Biochem 2008;41:1326-9.
36. Abilleira S, Bevan S, Markus HS. The role of genetic variants of matrix metalloproteinases in coronary and carotid atherosclerosis. J Med Genet 2006;43:897-901.